Patrick J. Gleeson - Publications

Mucin O-glycosylation and B-cell homing: a new bridge for the gut-kidney axis in IgA nephropathy?

Journal: Kidney international

Published: June 25, 2025

The Role of Mucosal Immunity: What Can We Learn From Animal and Human Studies?

Journal: Seminars in nephrology

Published: March 13, 2025

Autoantibodies Targeting Nephrin in Podocytopathies.

Journal: The New England journal of medicine

Published: October 09, 2024

Immunoglobulin A Antibodies: From Protection to Harmful Roles.

Journal: Immunological reviews

Published: September 25, 2024

The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis.

Journal: Science translational medicine

Published: March 27, 2024

IgA nephropathy in adults-treatment standard.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 12, 2023

CARD9, VAV3, and infection risk in IgA nephropathy.

Journal: Kidney international

Published: February 03, 2023

Treatment for Mild Chronic Hypertension during Pregnancy.

Journal: The New England journal of medicine

Published: September 07, 2022

Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology.

Journal: Clinical kidney journal

Published: August 25, 2022

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?

Journal: Microorganisms

Published: February 07, 2022

Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.

Journal: Kidney international

Published: May 11, 2021

Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies.

Journal: Molecular immunology

Published: April 15, 2021